23 April 2022 | A compositional analysis of physical activity, sedentary time, and sleep and associated health outcomes in children and adults with Cystic Fibrosis. | Bianchim, MS; McNarry, MA; Holland, A; et al. |
20 April 2022 | Calibration and Cross-validation of Accelerometry in Children and Adolescents with Cystic Fibrosis | Bianchim, MS; McNarry, MA; Evans, R; et al. |
2 December 2022 | Normal reference values for aerobic fitness in cystic fibrosis: a scoping review | Tomlinson, OW; Wadey, CA; Williams, CA |
22 December 2022 | Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease | Tomlinson, OW; Markham, L; Wollerton, RL; et al. |
14 December 2022 | Scaling Peak Oxygen Consumption for Body Size and Composition in People With a Fontan Circulation | Wadey, CA; Barker, AR; Stuart, G; et al. |
4 November 2022 | Protecting the stars of tomorrow: do international cardiovascular preparticipation screening policies account for the paediatric athlete? A systematic review and quality appraisal | Riding, NR; Dorobantu, D-M; Williams, CA; et al. |
7 October 2022 | The use of 2-D speckle tracking echocardiography in assessing adolescent athletes with left ventricular hypertrabeculation meeting the criteria for left ventricular non-compaction cardiomyopathy | Dorobantu, DM; Radulescu, CR; Riding, N; et al. |
23 October 2021 | Investigating the Accuracy of Quantitative Echocardiographic-Modified Task Force Criteria for Arrhythmogenic Ventricular Cardiomyopathy in Adolescent Male Elite Athletes | Sharma, C; Dorobantu, DM; Ryding, D; et al. |